CHC Healthcare Group · TWSE:4164
CHC Healthcare — 2020 1st Investor Conference
32 slides from CHC Healthcare's conference presentation, Sep 25, 2020
Slide 1: CHC Healthcare Group 2020 1st Investor Conference
CHC Healthcare Group (4164TT) 2020 1st Investor Conference 2020/09/25
Slide 2: Disclaimer
• This document is provided by CHC Healthcare Group (CHC). Information contained in this document has not been audited or reviewed by any accountants or independent experts. CHC makes no express or implied representations or warranties as to the fairness, accuracy, completeness, or correctness of su
Slide 3: Dual ISO Certifications
Dual ISO Certifications ISO 9001 Quality Management Systems OHSAS 18001 Occupational Health and Safety Management Systems
Slide 4: Company Overview
Company Business Future Overview Results Guidance
Slide 5: Company Overview
Company Business Future Overview Results Guidance
Slide 6: Basic Information
Basic Information • Name: CHC Healthcare Group (4164 TT) • Date of establishment: 2009/11/27 (1st subsidiary, Chiu Ho Instruments & Reagent, was founded in 1977) • President Mr. Pei-Lin, Lee • Headquarters Taipei • Branches Taichung, Kaohsiung, Guangzhou, Beijing, Shenyang & Jakarta • Major business
Slide 7: Milestones
Milestones Established Chiu Ho Instruments & Reagents Co., Ltd. to engage in Listed in Taiwan Stock Exchange 1977 business of medical equipment distribution 2012 Became Taiwan exclusive distributor for IBA of proton therapy systems 1985 Entered the field of radiation oncology equipment Became Taiwan
Slide 8: Business Model
Business Model Manufacturer Medical Medical Equipment CHC Management Distribution Service Hospital & Clinic
Slide 9: Solid Partnership with Top Global Brands
Solid Partnership with Top Global Brands Radiation Oncology Neuroscience Ophthalmology Medical Imaging Surgery
Slide 10: Medical Management Service Model
Medical Management Service Model Operation Division Consulting Management Hospital Management Equipment Provider
Slide 11: Business Results
Company Business Future Overview Results Guidance
Slide 12: Product Mix
Product Mix 2019 2020 H1 2018 2019 H1 56% 44% 48% 52% 55% 45% 47% 53% Revenue from medical equipment distribution Revenue from medical management service
Slide 13: Operating Revenue
Operating Revenue Operating revenue (NT$ thousand) 3,500,000 2,950,052 3,000,000 2,507,466 2,500,000 2,205,206 2,117,116 2,001,607 2,000,000 1,670,412 1,500,000 1,000,000 500,000 - 2016 2017 2018 2019 2019 Jan.- Aug. 2020 Jan.- Aug. (Self-assessed) (Self-assessed)
Slide 14: Profitability
Profitability Profit for the period Basic EPS (NT$ thousand) (NT$ ) 500,000 3 2.83 2.5 400,000 2.32 2 300,000 1.5 200,000 1.14 1.18 1.15 1 0.5 100,000 0 - 390,431 159,623 -0.5 160,604 -0.62 317,829 160,909 -100,000 -1 -89,286 2016 2017 2018 2019 2019 H1 2020 H1
Slide 15: Earnings Distribution & Dividend Yield
Earnings Distribution & Dividend Yield Cash dividends Dividend per share yield (NT$) 3 6% Cash dividends Average Dividend 2.5 5% per share closing price yield (NT$) 2 4% 2016 1.004 49.68 2% 2017 1.1 40.69 3% 1.5 3% 2018 1.8 33.87 5% 1 2% 2019 2 40.27 5% 0.5 1% 0 0% 2016 2017 2018 2019
Slide 16: Future Guidance
Company Business Future Overview Results Guidance
Slide 17: Future Guidance
Future Guidance Enrich Advance Product Line Service Quality Expand Extend Overseas Market Diversified Business
Slide 18: Enrich Product Line - Elekta MR-Linac
Enrich Product Line - Elekta MR-Linac
Slide 19: Enrich Product Line - Cyberdyne HAL
Enrich Product Line - Cyberdyne HAL®
Slide 20: Enrich Product Line - Cyberdyne HAL
Enrich Product Line - Cyberdyne HAL® *Source: The Japan Times, YouTube
Slide 21: Enrich Product Line - Welch Allyn Spot Vision Screener
Enrich Product Line - Welch Allyn Spot Vision Screener
Slide 22: Advance Service Quality
Cc bs Cc HEALTHCARE Sy GROUP Advance Service Quality
Slide 23: Advance Service Quality
Advance Service Quality Site Planning Maintenance Site & Upgrade Construction Service Scope Education Operational & Training Consulting Installation
Slide 24: Advance Service Quality
Advance Service Quality Yee-Min, Jen Chief Executive Officer Oncology Business Group (Director, Dept. of Radiation Oncology, Tri-Service General Hospital) Ming-Ta, Wen Dr. Chia-Ming, Wu Physician Oncology Business Group Oncology Business Group (Supervisor, Dept. of Radiation Oncology, Mennonite Chri
Slide 25: Expand Overseas Market
Expand Overseas Market Branches Taiwan China Indonesia • Taipei • Guangzhou • Jakarta • Taichung • Beijing • Kaohsiung • Shenyang
Slide 26: Expand Overseas Market - China
Expand Overseas Market - China
Slide 27: Expand Overseas Market - Indonesia
Expand Overseas Market - Indonesia
Slide 28: Extend Diversified Business - Develop iROIS
Extend Diversified Business - Develop iROIS Information Platform for Clinical Operations Comprehensive Radiation Oncology Solution
Slide 29: Why iROIS?
Extend Diversified Business - Develop iROIS Why iROIS? Information Integration Intelligent Monitoring Electronic Six Treatment Forms Solutions Quality Paperless Lower Standard Operations Costs Workflow Patient Efficient Safety Platform
Slide 30: Extend Diversified Business - Enter Elderly Care Industry
Extend Diversified Business - Enter Elderly Care Industry
Slide 31: Extend Diversified Business - Enter Elderly Care Industry
Extend Diversified Business - Enter Elderly Care Industry • Aging in Place • Preventive Medicine • Continuing Care
Slide 32: Thank you!
Thank you! www.chcg.com Copyright © 2019 CHC Limited. All rights reserved.